Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III study

BACKGROUND: We compared the efficacy and safety of low-intensity atorvastatin and ezetimibe combination therapy with moderate-intensity atorvastatin monotherapy in patients requiring cholesterol-lowering therapy. METHODS: At 19 centers in Korea, 290 patients were randomized to 4 groups: atorvastatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seung-Ah, Hong, Soon Jun, Sung, Jung-Hoon, Kim, Kyung-Soo, Kim, Seong Hwan, Cho, Jin Man, Chun, Sung Wan, Lee, Sang Rok, Kim, Chul Sik, Kim, Tae Nyun, Kim, Dae Hyeok, Park, Hwan-Cheol, Kim, Byung Jin, Kim, Hyun-Sook, Choi, Ji-Yong, Hong, Young Joon, Chung, Joong Wha, Yoon, Seong Bo, Lee, Sang-Hak, Lee, Cheol Whan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681377/
https://www.ncbi.nlm.nih.gov/pubmed/38013289
http://dx.doi.org/10.1097/MD.0000000000036122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681377/
https://www.ncbi.nlm.nih.gov/pubmed/38013289
http://dx.doi.org/10.1097/MD.0000000000036122

Ejemplares similares